Biosynth offers a product base of over 100,000 biochemicals for the diagnostics, pharmaceutical and chemical industries as well as food and environmental analysis. Its main production and HQ are in Switzerland, with sites in Slovakia, the USA and China. 

Carbosynth is a supplier of carbohydrates, nucleosides, and biochemicals to research and development scientists in the pharmaceutical and biotechnology industries. Established in 2006 near Oxford, the company has operations in the UK, USA, and China, a catalogue portfolio of 150,000 products, and custom synthesis and contract manufacturing services.

We were engaged to find talent management solutions in order to facilitate the restructuring of the combined business post-merger. We introduced a number of candidates to Biosynth enabling the deal to proceed with certainty that there were a number of talent solutions available.

Steve Mothersole, CCD Partners, commented:

“We were delighted to have been chosen to source the next generation of leader for the business post merger. Having to attract senior talent to a business before a transaction concludes and, necessarily, needing to do so under conditions of extreme secrecy poses its own challenges. Despite this, I am delighted to say our team was successful in lining up several well-qualified candidates allowing our client to conclude the transaction with confidence in the future team. We look forward to working with the enlarged business going forward.”